Bodyport is a digital therapeutics (DTx) company focused on empowering individuals to live free from complex chronic conditions. By leveraging unique health signals and simple, at-home experiences, the company delivers actionable insights. Bodyport is dedicated to advancing the standard of care for conditions like heart failure by integrating a sophisticated biomarker platform into easy-to-use devices, ultimately aiding patients and care teams in better predicting, understanding, and intervening in changes to heart health, thus reducing hospital visits. The platform noninvasively measures a broad spectrum of hemodynamic biomarkers to assess heart function and fluid status, providing comprehensive health insights directly to individuals at home. Founded in 2014 and headquartered in the United States, the company received a $11.20M Series A investment on 11 August 2020 from a group of investors including HCVC, Kapor Capital, Initialized Capital, Playground Global, BIVF, and El Cap Ventures. With its innovative approach and focus on digital therapeutics, Bodyport holds significant potential for contributing to the improvement of chronic condition management in the healthcare industry. Learn more about the company at bodyport.com.
Bodyport
Digital therapeutics for cardiorenal conditions.
San Francisco, United States
22 employees
Series A
Total: $15.82M
Health Care
General Information
San Francisco, United States
BounceWatch is an independent company data service, not affiliated with Bodyport. To contact Bodyport, visit bodyport.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Bodyport compare?
A PDF of Bodyport and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Bodyport soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Health Care
About Bodyport
Business keywords: Digital Therapeutics, Cardiorenal Conditions, Chronic Conditions, Health Signals, Biomarker Platform, Heart Failure, At-Home Health Monitoring, Noninvasive Health Assessment, Health Insights, Chronic Disease Management, Remote Patient Monitoring, Health Technology, Telehealth, Healthcare Innovation
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | $11.20M | 6 |
|
11 Aug 2020 |
| Seed Round | $2.00M | 1 |
|
01 Feb 2018 |
| Seed Round | $2.50M | 3 |
|
01 Feb 2016 |
| Seed Round | $120.00K | - |
|
18 Aug 2015 |
Bodyport Alternatives & Competitors
Our mission is to make every day easier for everyone with complex health and those who care for them...
Creating continuous care in diabetes
The difference is vivid.™
FAQ About Bodyport
Source: BounceWatch company record for Bodyport, https://bouncewatch.com/company/bodyport, updated 24 October 2024. When citing, please name BounceWatch and link this page.
